Consent Action of the Board of Directors of Electromedical Technologies, Inc. Authorizing Stock Issuance to Satisfy Promissory Note
Electromedical Technologies, Inc., through its sole director Matthew N. Wolfson, approved the issuance of 63,380 restricted common shares to Nikolai Ogorodnikov. This issuance fully settles a $45,000 debt owed to Ogorodnikov under a promissory note dated October 31, 2013. The shares are valued at $0.71 each. The company's transfer agent, Pacific Stock Transfer, is authorized to issue the shares to Ogorodnikov at his specified address. No further board actions were taken at this meeting.
Exhibit 10.15
CONSENT ACTION OF THE BOARD OF DIRECTORS OF
ELECTROMEDICAL TECHNOLOGIES, INC.
The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation, (the “Company”), hereby unanimously consent to the following actions taken on Company on October 11, 2019.
RESOLVED: To issue Nikolai Ogorodnikov (“Ogorodnikov”) a total of 63,380 shares of the Company’s restricted common stock in full and complete satisfaction of any and all claims which Ogorodnikov may have against the Company the pursuant to that certain Promissory Note by and between Ogorodnikov and the Company dated October 31, 2013. The total amount owed to Ogorodnikov was $45,000 and the shares are valued at $0.71 per share.
RESOLVED: That the Company’s transfer agent, Pacific Stock Transfer, is hereby authorized to issue the foregoing shares to Ogorodnikov at the following address: 228 S. Doheny Dr., Apt. #4, Beverly Hills, CA 90211.
There being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned.
Matthew N. Wolfson
Sole Director
